BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32251836)

  • 1. Prevention of Recurrent Mucinous Borderline Ovarian Tumor with Aromatase Inhibitor.
    Stambough KC; Muscal JA; Edwards CL; Dietrich JE
    J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):610-612. PubMed ID: 32251836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
    Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
    Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
    Kuji S; Harada M; Yoshioka N; Kajiyama H; Satoh T; Mikami M; Shozu M; Enomoto T; Osuga Y; Suzuki N
    J Obstet Gynaecol Res; 2022 Mar; 48(3):806-816. PubMed ID: 34951514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
    Chen R; Zhu T; Yu H; Zhu J; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
    Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
    Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based study.
    Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
    Fertil Steril; 2021 Jan; 115(1):157-163. PubMed ID: 32977941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
    Childress KJ; Patil NM; Muscal JA; Dietrich JE; Venkatramani R
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):48-54. PubMed ID: 28899828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.
    Beroukhim G; Ozgediz D; Cohen PJ; Hui P; Morotti R; Schwartz PE; Yang-Hartwich ; Vash-Margita A
    J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):359-367. PubMed ID: 34843973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
    Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
    Li N; Ming X; Li Z
    Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
    Wang L; Zhong Q; Tang Q; Wang H
    Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline ovarian tumors: outcomes of fertility sparing surgery.
    Ozalp SS; Yalcin OT; Telli E; Oge T; Kabukcuoglu S
    Eur J Gynaecol Oncol; 2014; 35(2):154-6. PubMed ID: 24772918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
    Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
    Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours].
    Gauroy E; Larouzée E; Chéreau E; De La Motte Rouge T; Margueritte F; Sallée C; Lacorre A; Gauthier T; Koskas M
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):314-321. PubMed ID: 32004781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
    Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
    Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.